EUVIMEDEUVIMED entdecken
Crossref

The HSP70 and IL ‐1β of Nile tilapia as molecular adjuvants can enhance the immune protection of DNA vaccine against Streptococcus agalactiae infection

Fei-Fan Xu, Zhu-Yang Deng, Jun-Jie Sheng, Bin Zhu iD

Journal of Fish Diseases · 2024

DOI: 10.1111/jfd.14002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Fish Diseases, 2024. Verfasst von Fei-Fan Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science and Technology, Northwest A&F University, Yangling, China. Hauptthemen laut MEDLINE: Fish Diseases, Streptococcus agalactiae, Vaccines, DNA, Streptococcal Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Globally, streptococcal disease caused by Streptococcus agalactiae is known for its high mortality rate, which severely limits the development of the tilapia breeding industry. As a third‐generation vaccine, DNA vaccines have shown great application prospects in the prevention and control of aquatic diseases, but their low immunogenicity limits their development. The combination of DNA vaccines and molecular adjuvants proved to be an effective method for inducing protective immunity. This study constructed recombinant plasmids encoding tilapia HSP70 and IL‐1β genes (pcHSP70 and pcIL‐1β) to verify their effectiveness as molecular adjuvants for S. agalactiae DNA vaccine (pcSIP) in the immunized tilapia model. The results revealed that serum‐specific IgM production, enzyme activities, and immune‐related gene expression in tilapia immunized with pcSIP plus pcHSP70 or pcIL‐1β were significantly higher than those in tilapia immunized with pcSIP alone. It is worth noting that combination with molecular adjuvants improved the immune protection of DNA vaccines, with a relative percentage survival (RPS) of 51.72% (pcSIP plus pcHSP70) and 44.83% (pcSIP plus pcIL‐1β), respectively, compared with that of pcSIP alone (24.14%). Thus, our study indicated that HSP70 and IL‐1β in tilapia are promising molecular adjuvants of the DNA vaccine in controlling S. agalactiae infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fish DiseasesStreptococcus agalactiaeVaccines, DNAStreptococcal InfectionsInterleukin-1betaCichlidsAdjuvants, ImmunologicHSP70 Heat-Shock ProteinsAnimalsFish ProteinsStreptococcal Vaccines

Stichwörter der Autor:innen

Streptococcus agalactiaeDNA vaccineimmune protectionmolecular adjuvantsurface immunogenic protein

Substanzen

Vaccines, DNAInterleukin-1betaAdjuvants, ImmunologicHSP70 Heat-Shock ProteinsFish ProteinsStreptococcal Vaccines

Autor:innen und Institutionen

  • College of Animal Science and Technology, Northwest A&F University, Yangling, China.
  • Engineering Research Center of the Innovation and Development of Green Fishery Drugs, Northwest A&F University, Yangling, China.

ORCID-Profile: Bin Zhu

Zitieren

APA

Xu, F. F., Deng, Z. Y., Sheng, J. J., & Zhu, B. (2024). The HSP70 and IL ‐1β of Nile tilapia as molecular adjuvants can enhance the immune protection of DNA vaccine against Streptococcus agalactiae infection. Journal of Fish Diseases. https://doi.org/10.1111/jfd.14002

Vancouver

Xu FF, Deng ZY, Sheng JJ, Zhu B. The HSP70 and IL ‐1β of Nile tilapia as molecular adjuvants can enhance the immune protection of DNA vaccine against Streptococcus agalactiae infection. Journal of Fish Diseases. 2024. doi:10.1111/jfd.14002

BibTeX
@article{Xu2024,
  author = {Xu, Fei-Fan and Deng, Zhu-Yang and Sheng, Jun-Jie and Zhu, Bin},
  title = {The HSP70 and IL ‐1β of Nile tilapia as molecular adjuvants can enhance the immune protection of DNA vaccine against Streptococcus agalactiae infection},
  journal = {Journal of Fish Diseases},
  year = {2024},
  doi = {10.1111/jfd.14002}
}
Kostenlos starten →